1
Tatyana Dyakonov, Sunil Agnihotri, Aqeel A Fatmi: Controlled release fumarate esters. Banner Life Sciences, Brinks Gilson & Lione, May 3, 2016: US09326947 (3 worldwide citation)

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral pharmaceutical compositions comprising controlled release fumarate esters are described.


2
Tatyana Dyakonov, Sunil Agnihotri, Aqeel A Fatmi: Controlled release fumarate esters. Banner Life Sciences, Brinks Gilson & Lione, May 3, 2016: US09326965 (3 worldwide citation)

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral pharmaceutical compositions comprising controlled release fumarate esters are described.


3
Susan Marie Royalty, James Ford Burns, Jan Jozef Scicinski, Gunnar Erik Jagdmann Jr, Robert James Foglesong, Kellee Griffin Ring, Tatyana Dyakonov, David Middlemiss: Peptidase inhibitors. Nuada, Myers Bigel Sibley & Sajovec PA, November 30, 2010: US07842707 (2 worldwide citation)

The present invention relates to a series of novel compounds having the formula (I) wherein: X is NR3 or O; n is 1 or 2; A is a bicyclic carbocycle and R1 and R2 are as described herein. The compounds are useful as DPP-IV inhibitors, such as for the treatment of diabetes.


4
Tatyana Dyakonov, Sunil Agnihotri, Aqeel A Fatmi: Fumarate ester pharmaceutical compositions. Banner Life Sciences, Brinks Gilson & Lione, December 13, 2016: US09517209 (1 worldwide citation)

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral pharmaceutical compositions comprising fumarate esters are described.


5
Tatyana Dyakonov, Sunil Agnihotri, Aqeel A Fatmi: Fumarate ester pharmaceutical compositions. Banner Life Sciences, Brinks Gilson & Lione, December 6, 2016: US09511043 (1 worldwide citation)

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral pharmaceutical compositions comprising fumarate esters are described.


6
Jason M Vaughn, Justin R Hughey, Tanesha Roberts, Tatyana Dyakonov, Sunil Agnihotri, Aqeel A Fatmi: Fumarate ester dosage forms. BANNER LIFE SCIENCES, Brinks Gilson & Lione, May 2, 2017: US09636319

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral controlled release pharmaceutical compositions comprising fumarate esters suspended in liquid matrices are described. One e ...


7
Jason M Vaughn, Justin R Hughey, Tanesha Roberts, Tatyana Dyakonov, Sunil Agnihotri, Aqeel A Fatmi: Fumarate ester dosage forms. BANNER LIFE SCIENCES, Brinks Gilson & Lione, February 14, 2017: US09566259

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral controlled release pharmaceutical compositions comprising fumarate esters suspended in liquid matrices are described. One e ...


8
Jason M Vaughn, Justin R Hughey, Tanesha Roberts, Tatyana Dyakonov, Sunil Agnihotri, Aqeel A Fatmi: Fumarate ester dosage forms. BANNER LIFE SCIENCES, Brinks Gilson & Lione, May 2, 2017: US09636318

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral controlled release pharmaceutical compositions comprising fumarate esters suspended in liquid matrices are described. One e ...


9
Nnochiri N Ekwuribe, Tatyana Dyakonov, Christopher H Price: Drug-oligomer conjugates. Myers Bigel Sibley & Sajovec, December 16, 2004: US20040253206-A1

Drug-oligomer conjugates and pharmaceutical compositions prepared therefrom. Methods of making and using the drug-oligomer conjugates and pharmaceutical compositions.


10
Tatyana Dyakonov, Michael L Jones, Christopher J Markworth, Jessymol Mathew, Frank J Schoenen, David S Van Vliet, David Middlemiss: Compounds and Methods of Use Thereof. Alston & Bird, October 30, 2008: US20080269204-A1

Benzolactam boronic acid compounds and pharmaceutical formulations are described along with methods of use thereof for inhibiting inflammatory cytokines such as tumor necrosis factor alpha (TNF-α) in a subject in need thereof.



Click the thumbnails below to visualize the patent trend.